These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27161043)

  • 1. GlyT1 Inhibitor NFPS Exerts Neuroprotection via GlyR Alpha1 Subunit in the Rat Model of Transient Focal Cerebral Ischaemia and Reperfusion.
    Huang B; Xie Q; Lu X; Qian T; Li S; Zhu R; Yu W; Chen G; Chen Z; Xu X; Wang T; Li L
    Cell Physiol Biochem; 2016; 38(5):1952-62. PubMed ID: 27161043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology and expression analysis of glycine transporter GlyT1 with [3H]-(N-[3-(4'-fluorophenyl)-3-(4'phenylphenoxy)propyl])sarcosine.
    Mallorga PJ; Williams JB; Jacobson M; Marques R; Chaudhary A; Conn PJ; Pettibone DJ; Sur C
    Neuropharmacology; 2003 Oct; 45(5):585-93. PubMed ID: 12941372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmembrane domains 1 and 3 of the glycine transporter GLYT1 contain structural determinants of N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)-propyl]sarcosine specificity.
    Núñez E; Martínez-Maza R; Geerlings A; Aragón C; López-Corcuera B
    Neuropharmacology; 2005 Nov; 49(6):922-34. PubMed ID: 16143353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The glycine transporter type 1 inhibitor N-[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine potentiates NMDA receptor-mediated responses in vivo and produces an antipsychotic profile in rodent behavior.
    Kinney GG; Sur C; Burno M; Mallorga PJ; Williams JB; Figueroa DJ; Wittmann M; Lemaire W; Conn PJ
    J Neurosci; 2003 Aug; 23(20):7586-91. PubMed ID: 12930797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological assessment of the role of the glycine transporter GlyT-1 in mediating high-affinity glycine uptake by rat cerebral cortex and cerebellum synaptosomes.
    Herdon HJ; Godfrey FM; Brown AM; Coulton S; Evans JR; Cairns WJ
    Neuropharmacology; 2001 Jul; 41(1):88-96. PubMed ID: 11445189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rescue of hippocampal LTP and learning deficits in a rat model of psychosis by inhibition of glycine transporter-1 (GlyT1).
    Manahan-Vaughan D; Wildförster V; Thomsen C
    Eur J Neurosci; 2008 Oct; 28(7):1342-50. PubMed ID: 18973561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine (NFPS) is a selective persistent inhibitor of glycine transport.
    Aubrey KR; Vandenberg RJ
    Br J Pharmacol; 2001 Dec; 134(7):1429-36. PubMed ID: 11724748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the strychnine-sensitive glycine receptor in the anxiolytic effects of GlyT1 inhibitors on maternal separation-induced ultrasonic vocalization in rat pups.
    Komatsu H; Furuya Y; Sawada K; Asada T
    Eur J Pharmacol; 2015 Jan; 746():252-7. PubMed ID: 25435080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The glycine transporter-1 inhibitors NFPS and Org 24461: a pharmacological study.
    Harsing LG; Gacsalyi I; Szabo G; Schmidt E; Sziray N; Sebban C; Tesolin-Decros B; Matyus P; Egyed A; Spedding M; Levay G
    Pharmacol Biochem Behav; 2003 Mar; 74(4):811-25. PubMed ID: 12667895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effect of taurine against focal cerebral ischemia in rats possibly mediated by activation of both GABAA and glycine receptors.
    Wang GH; Jiang ZL; Fan XJ; Zhang L; Li X; Ke KF
    Neuropharmacology; 2007 Apr; 52(5):1199-209. PubMed ID: 17386936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The glycine transport inhibitor sarcosine is an inhibitory glycine receptor agonist.
    Zhang HX; Lyons-Warren A; Thio LL
    Neuropharmacology; 2009; 57(5-6):551-5. PubMed ID: 19619564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurochemical and behavioral profiling of the selective GlyT1 inhibitors ALX5407 and LY2365109 indicate a preferential action in caudal vs. cortical brain areas.
    Perry KW; Falcone JF; Fell MJ; Ryder JW; Yu H; Love PL; Katner J; Gordon KD; Wade MR; Man T; Nomikos GG; Phebus LA; Cauvin AJ; Johnson KW; Jones CK; Hoffmann BJ; Sandusky GE; Walter MW; Porter WJ; Yang L; Merchant KM; Shannon HE; Svensson KA
    Neuropharmacology; 2008 Oct; 55(5):743-54. PubMed ID: 18602930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycine transporters type 1 inhibitor promotes brain preconditioning against NMDA-induced excitotoxicity.
    Pinto MC; Lima IV; da Costa FL; Rosa DV; Mendes-Goulart VA; Resende RR; Romano-Silva MA; de Oliveira AC; Gomez MV; Gomez RS
    Neuropharmacology; 2015 Feb; 89():274-81. PubMed ID: 25312280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [
    Frouni I; Kim E; Shaqfah J; Bédard D; Kwan C; Belliveau S; Huot P
    Exp Brain Res; 2024 May; 242(5):1203-1214. PubMed ID: 38526743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effects of diallyl sulfide against transient focal cerebral ischemia via anti-apoptosis in rats.
    Lin X; Yu S; Chen Y; Wu J; Zhao J; Zhao Y
    Neurol Res; 2012 Jan; 34(1):32-7. PubMed ID: 22196859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effect of 4-hydroxybenzyl alcohol against transient focal cerebral ischemia via anti-apoptosis in rats.
    Yu SS; Zhao J; Zheng WP; Zhao Y
    Brain Res; 2010 Jan; 1308():167-75. PubMed ID: 19857470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of glycine transporter-1 (GLYT-1) potentiates NMDA receptor-mediated synaptic transmission in hypoglossal motorneurons.
    Lim R; Hoang P; Berger AJ
    J Neurophysiol; 2004 Oct; 92(4):2530-7. PubMed ID: 15175365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of striatal dopamine release by glycine transport inhibitors.
    Javitt DC; Hashim A; Sershen H
    Neuropsychopharmacology; 2005 Apr; 30(4):649-56. PubMed ID: 15688094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and D-serine.
    Hashimoto K; Fujita Y; Ishima T; Chaki S; Iyo M
    Eur Neuropsychopharmacol; 2008 Jun; 18(6):414-21. PubMed ID: 17804206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
    Mezler M; Hornberger W; Mueller R; Schmidt M; Amberg W; Braje W; Ochse M; Schoemaker H; Behl B
    Mol Pharmacol; 2008 Dec; 74(6):1705-15. PubMed ID: 18815213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.